(31D1.F)
- Previous Close
127.80 - Open
123.80 - Bid 119.20 x --
- Ask 127.40 x --
- Day's Range
121.40 - 123.80 - 52 Week Range
121.20 - 136.00 - Volume
60 - Avg. Volume
3 - Market Cap (intraday)
2.038B - Beta (5Y Monthly) 1.24
- PE Ratio (TTM)
61.94 - EPS (TTM)
1.96 - Earnings Date Jul 22, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 18, 2024
- 1y Target Est
--
Dätwyler Holding AG engages in the production and sale of elastomer components for healthcare, mobility, connectors, general, and food and beverage industries in Europe, North America, South America, Australia, and Asia. It operates through Healthcare Solutions and Industrial Solutions segments. The Healthcare Solutions segment offers rubber components for prefilled syringes, pens, and injection systems; components and closures for injectable drugs in vials; and rubber components for blood collection systems, IV administration sets, disposable syringes, diagnostics and medical devices, etc. The Industrial Solutions segment products include batteries and powertrains in electric vehicles, brake systems, interior and active assistance and safety systems in all cars, as well as fuel and engine management and exhaust gas aftertreatment in combustion engines; seals and components for electrical connectors; sealing solutions; and sealing components for upstream systems in the oil and gas, aerospace, heavy machinery, power tools and process, and water treatment industries. The company was founded in 1915 and is based in Altdorf, Switzerland. Dätwyler Holding AG operates as a subsidiary of Pema Holding AG.
www.datwyler.com8,030
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 31D1.F
View MorePerformance Overview: 31D1.F
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 31D1.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 31D1.F
View MoreValuation Measures
Market Cap
2.15B
Enterprise Value
2.62B
Trailing P/E
65.30
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.83
Price/Book (mrq)
5.51
Enterprise Value/Revenue
2.21
Enterprise Value/EBITDA
17.09
Financial Highlights
Profitability and Income Statement
Profit Margin
2.81%
Return on Assets (ttm)
6.27%
Return on Equity (ttm)
8.24%
Revenue (ttm)
1.11B
Net Income Avi to Common (ttm)
31.1M
Diluted EPS (ttm)
1.96
Balance Sheet and Cash Flow
Total Cash (mrq)
127.4M
Total Debt/Equity (mrq)
155.88%
Levered Free Cash Flow (ttm)
158.16M